adminの記事一覧

Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury.

Kidney Int. 87(3): 640-648, 2014.PubMed

Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.

Heart Vessels. 30(3): 362-368, 2014.PubMed

Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.

Diabetes Metab Res Rev. 30(8): 736-741, 2014.PubMed

Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir.

AIDS Res Hum Retroviruses. 30(4): 363-369, 2014.PubMed

Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit.

Nephrol Dial Transplant. 29(1): 73-80, 2014.PubMed

Urinary biomarkers and progression of AKI in patients with cirrhosis.

Clin J Am Soc Nephrol. 9(11): 1857-1867, 2014.PubMed

腎臓病が認知症の強力なリスク因子に　血液中に増えた尿素窒素が血液脳関門の機能異常に関与

■━━━━━━━━━━━━━━━━━━━━━━━━■腎疾患診断用バイオマーカー L-FABP情報サイト■□■□メールマガジン□■□■No.64／2024年1月配信号［医療者向け］https://fabp.jp/?utm_source=mailmagazine&utm_campaign=240

Biomarkers of acute kidney injury in pediatric cardiac surgery.

Clin Biochem. 46(13-14): 1244-1251, 2013.PubMed

Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis.

Am J Kidney Dis. 61(3): 430-439, 2013.PubMed

Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.

Clin J Am Soc Nephrol. 8(7): 1079-1088, 2013.PubMed